Meeting
2020 Genitourinary Cancers Symposium
New patient-derived models of castrate-sensitive and castrate-resistant prostate cancer.
Authors
Mitchell Lawrence
Prostate Cancer Research Group, Victoria, Australia
Mitchell Lawrence , David Clouston , Mark Frydenberg , Declan G. Murphy , Carmel Jo Pezaro , David William Pook , Heather Thorne , Shahneen Kaur Sandhu , Roxanne Toivanen , Renea Taylor , Gail Risbridger
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 151)
Abstract #
151
Poster Bd #
G9
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
SPOP mutations in prostate cancer: Clinical and genomic features.
First Author: Mari Nakazawa
Poster
2013 ASCO Quality Care Symposium
Application of a novel method weighing drug costs against survival in castrate-resistant prostate cancer cancer.
First Author: Helmy M. Guirgis
Poster
2023 ASCO Genitourinary Cancers Symposium
Genomic, clinical characteristics, and treatment outcomes of patients with metastatic castration-sensitive prostate cancer with SPOP mutations: Analysis from the Kaiser Permanente Northern California Healthcare System.
First Author: Sachdev P. Thomas
Poster
2023 ASCO Genitourinary Cancers Symposium
Racial differences in survival and healthcare resource utilization among Medicaid-insured adults with metastatic castration-resistant prostate cancer.
First Author: Maral DerSarkissian